Your browser doesn't support javascript.
loading
Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care.
Patorno, Elisabetta; Gopalakrishnan, Chandrasekar; Brodovicz, Kimberly G; Meyers, Andrea; Bartels, Dorothee B; Liu, Jun; Kulldorff, Martin; Schneeweiss, Sebastian.
Afiliação
  • Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Gopalakrishnan C; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Brodovicz KG; Department of Global Epidemiology, Boehringer Ingelheim Pharmaceuticals, Inc (U.S), Ingelheim, Germany.
  • Meyers A; Department of Global Epidemiology, Boehringer Ingelheim Pharmaceuticals, Inc (U.S), Ingelheim, Germany.
  • Bartels DB; Hannover Medical School, Institute for Epidemiology, Social Medicine and Health Systems Research, Hannover, Germany.
  • Liu J; BI X, Boehringer Ingelheim GmbH, Ingelheim, Germany.
  • Kulldorff M; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Diabetes Obes Metab ; 21(8): 1824-1836, 2019 08.
Article em En | MEDLINE | ID: mdl-30941884
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Angiopatias Diabéticas / Inibidores da Dipeptidil Peptidase IV / Linagliptina / Hipoglicemiantes Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Angiopatias Diabéticas / Inibidores da Dipeptidil Peptidase IV / Linagliptina / Hipoglicemiantes Idioma: En Ano de publicação: 2019 Tipo de documento: Article